- Forbes•22 hours ago
Frazier took the stage at Forbes Healthcare Summit in New York to discuss the changing landscape of cancer treatment with fellow heavy hitters and shared his thoughts on everything from cost vs. value to how one drug breakthrough leads to others.
- American City Business Journals•3 days ago
Tech Data Corp. has doubled the number of women on its board of directors. Bridgette Heller, a member of the executive committee of French food products company Danone, was appointed to the Tech Data (TECD) board late last month. Diverse companies are more likely to have financial returns above their national industry medians, and are better able to win top talent and improve their customer orientation, according to management consulting firm McKinsey & Co.
- Market Realist•3 days ago
AbbVie (ABBV) and Roche Holdings (RHHBY) have completed a Phase 1 trial evaluating the use of Venclexta as a therapy for multiple myeloma patients.
MRK.BA : Summary for MERCK & CO INC CEDEAR (10 REP 1 - Yahoo Finance
Merck & Co., Inc. (MRK.BA)
Buenos Aires - Buenos Aires Delayed Price. Currency in ARS
Add to watchlist
|Day's Range||98.85 - 98.85|
|52 Week Range||98.85 - 98.85|
|PE Ratio (TTM)||50.49|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|